Table 1.
Characteristics | Number of patients | OPN protein expression
|
P-valuea | |
---|---|---|---|---|
Low | High | |||
Gender | 0.432 | |||
Male | 42 | 18 | 24 | |
Female | 31 | 13 | 18 | |
Age (years) | 0.417 | |||
<65 | 47 | 19 | 28 | |
≥65 | 26 | 12 | 14 | |
Pathologic type | 0.356 | |||
SCC | 39 | 17 | 22 | |
AC | 34 | 14 | 20 | |
Smoking history | 0.281 | |||
Yes | 58 | 26 | 32 | |
No | 15 | 5 | 10 | |
Differentiation | 0.031b | |||
Low | 2 | 1 | 1 | |
Moderate | 55 | 26 | 29 | |
High | 16 | 4 | 12 | |
Metastasis | 0.019b | |||
M0 | 32 | 21 | 11 | |
M1 | 41 | 11 | 30 | |
Response | 0.038b | |||
PR | 27 | 12 | 15 | |
SD | 38 | 18 | 20 | |
PD | 8 | 2 | 6 |
Notes:
Pearson chi-square test;
significant.
Abbreviations: AC, adenocarcinoma; NSCLC, non-small-cell lung cancer; PD, progressive disease; PR, partial response; SCC, squamous cell carcinoma; SD, stable disease; OPN, osteopontin.